ETNB

89bio Inc (ETNB)

US
$ 8.3510.74%

Price Chart

Key Statistics

Market Cap
$ 1.48B
P/E Ratio
0.00
Revenue (TTM)
$ 0
Volume
2.42M
52W High
$ 11.84
52W Low
$ 4.16
Dividend Yield
0.00%
Beta
1.53

Technicals

50-Day MA
9.0718
200-Day MA
8.4047
52 Week High
11.84
52 Week Low
4.16

About ETNB

89bio, Inc., a clinical-stage biopharmaceutical company, engages in the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases.

Employees
93
Headquarters
San Francisco, CA
CEO
Mr. Rohan Palekar

Latest News

Advanced Charts

Access professional-grade trading charts and technical analysis tools

Top Gainers

Symbol/Name
LTP
% Chg
JELD
JELD-WEN Holding In...
$ 4.40
12.24
LVS
Las Vegas Sands Cor...
$ 47.36
8.87
CCS
Century Communities...
$ 61.22
8.70
KTB
Kontoor Brands Inc....
$ 71.65
8.61
BBWI
Bath & Body Works I...
$ 32.40
8.14

Top Losers

Symbol/Name
LTP
% Chg
ACHR
Archer Aviation Inc...
$ 9.97
-8.11
AMC
AMC Entertainment H...
$ 2.87
-7.42
OKLO
Oklo Inc.
$ 52.29
-6.58
QS
QuantumScape Corpor...
$ 6.29
-6.40
SE
Sea Limited America...
$ 150.49
-5.96